Since two-thirds of the biotechnology products on the European market are coming out of clinical trials performed in the United Kingdom, Georgia biotechnology start-ups should be looking to British…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Phil Bolton is the founder and publisher emeritus of Global Atlanta.